logo
Brazil trade restrictions after bird flu outbreak

Brazil trade restrictions after bird flu outbreak

Reuters21-05-2025
SAO PAULO, May 21 (Reuters) - The Brazilian Agriculture Ministry on Wednesday updated the list of countries that have placed restrictions on chicken trade with the world's largest exporter after it confirmed its first case of bird flu on a commercial farm.
The outbreak was identified in the city of Montenegro in the southern Brazilian state of Rio Grande do Sul.
China, the European Union, South Africa, Peru, Dominican Republic, Bolivia, Morocco, Sri Lanka, Pakistan - no change, in line with existing protocols
Mexico, South Korea, Chile, Canada, Uruguay, Malaysia, Argentina - no change to announced suspensions
Iraq, the Eurasian Union, East Timor, the Philippines, Jordan - added to list
SUSPENSIONS TARGETING RIO GRANDE DO SUL STATE
United Kingdom, Bahrain, Cuba - no change to announced suspensions
Macedonia, Montenegro, Kazakhstan, Bosnia and Herzegovina, Ukraine, Tajikistan - added to list
SUSPENSIONS TARGETING MONTENEGRO CITY
Japan - no change to announced suspension
Saudi Arabia - added to list
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

China records more chikungunya cases as it battles 'largest outbreak'
China records more chikungunya cases as it battles 'largest outbreak'

Daily Mail​

time7 hours ago

  • Daily Mail​

China records more chikungunya cases as it battles 'largest outbreak'

Cases of chikungunya virus continue to rise in China, as the country battles its largest-ever outbreak of the illness. Another 1,387 cases of Chikungunya virus were confirmed last week, Chinese authorities said, with almost all in the southern manufacturing city of Foshan. It takes the tally to more than 10,000 cases overall, with infections also reported in Taiwan and Hong Kong , as well as in Europe and travel-acquired cases in the US. The reported figure for the latest week is, however, below that for the previous seven-day period at 2,892 cases, in a sign that the outbreak could now be slowing. Chinese officials say there have been no cases of severe disease or death reported during the outbreak. The spread of the mosquito-borne disease has triggered restrictions in China not seen since the Covid pandemic, with disinfectant sprayed in streets and patients quarantined in hospitals. Officials have also deployed insecticide-spraying drones, 'cannibal' mosquitoes and killer fish to eliminate any insects that could be carrying the virus. It has also triggered alarm in the US, with CDC officials saying they are 'assessing' the situation and warning Americans to take protective measures, such as wearing insect repellent or long-sleeved clothes if they travel to the area. Experts in the US say the disease is just 'one plane ride' from reaching American shores. China's record-breaking outbreak is in Guangdong province, on the southern coast, with almost all the infections reported in the city of Foshan. In the latest update from the Guangdong Provincial Center for Disease Control and Prevention, revealed by the Yangcheng Evening News, officials reported that of the new cases, 1,212 were in Foshan. Another 103 cases were reported in Guangzhou, the largest city in the province, while 39 cases were reported in Zhanjiang. It was not clear where the other 33 cases were within the province. Officials heralded the figures as the lowest weekly count reported since the peak of the outbreak in the week to July 20 to 26, when they said they recorded 2,940 cases. In a statement to last week, a CDC spokesman said: 'CDC is aware of the reported chikungunya outbreak in Guangdong Province in China and is currently assessing the size and extent of the outbreak.' The agency has already issued a level two warning for the area, advising Americans to take advanced precautions when traveling to the region. On Friday, Hong Kong said it had detected another two cases linked to the outbreak, taking its chikungunya tally to five infections reported this year. One was a 66-year-old woman who was reported to have traveled to Foshan alone from July 24 to August 5 to see family, before returning to Hong Kong. The patient began suffering from fever, rash and joint pain on August 6 and went to the hospital. She has now been discharged. It also reported another suspected case in a healthy 22-year-old woman who was suffering from joint pain and fever. She had recently traveled to Madagascar, Mauritius and Malaysia before returning to the territory, and reported having been bitten by mosquitoes during her trip. Also on Friday, Taiwan reported its first case linked to the outbreak in China, in a woman in her 40s who had recently returned from Foshan and Shenzhen. A day after returning to Taiwan she developed a fever, rash and pain in her limbs. Officials said she was admitted to the hospital. She also reported being bitten by mosquitoes. It is rarely fatal, but can leave people with lifelong complications including joint inflammation and pain that lasts for years. Patients who are very young, elderly or have underlying conditions are most at risk because of their weakened immune systems. There is no treatment for the virus, with doctors instead using over-the-counter painkillers, fluids and rest to ease symptoms. There are two vaccines available.

Sanofi stops supply of high cholesterol drug to China due to limited availability
Sanofi stops supply of high cholesterol drug to China due to limited availability

Reuters

time7 hours ago

  • Reuters

Sanofi stops supply of high cholesterol drug to China due to limited availability

SHANGHAI, Aug 12 (Reuters) - Sanofi ( opens new tab said on Tuesday it had stopped supplying Praluent, a popular cholesterol drug jointly developed by the French pharmaceuticals firm and its partner Regeneron Pharmaceuticals, in China due to limited availability. "The surge in demand has led to limited availability in China, and some other countries," Sanofi said in a statement sent to Reuters, adding "at the moment Praluent's supply in China has already stopped." It didn't say when supply would resume. Sanofi said it had "invested to strengthen global production of Praluent, to meet a rising global demand which accelerated sharply over the past two years". The company said clinical experts had found there were other medicines on China's National Reimbursement Drug List that were "safe and appropriate" for patients currently being treated with Praluent and it was working with healthcare providers in China to "ensure a smooth transition for patients". Sanofi is the latest foreign drugmaker to stop supplying popular medications to China. Merck (MRK.N), opens new tab suspended shipments of its blockbuster human papillomavirus vaccine Gardasil to the country in February, citing weak discretionary spending.

China records more cases of deadly chikungunya virus as country battles 'largest outbreak ever'
China records more cases of deadly chikungunya virus as country battles 'largest outbreak ever'

Daily Mail​

time20 hours ago

  • Daily Mail​

China records more cases of deadly chikungunya virus as country battles 'largest outbreak ever'

Cases of chikungunya virus continue to rise in China, as the country battles its largest-ever outbreak of the illness. Another 1,387 cases of Chikungunya virus were confirmed last week, Chinese authorities said, with almost all in the southern manufacturing city of Foshan. It takes the tally to more than 10,000 cases overall, with infections also reported in Taiwan and Hong Kong, as well as in Europe and travel-acquired cases in the US. The reported figure for the latest week is, however, below that for the previous seven-day period at 2,892 cases, in a sign that the outbreak could now be slowing. Chinese officials say there have been no cases of severe disease or death reported during the outbreak. The spread of the mosquito-borne disease has triggered restrictions in China not seen since the Covid pandemic, with disinfectant sprayed in streets and patients quarantined in hospitals. Officials have also deployed insecticide-spraying drones, 'cannibal' mosquitoes and killer fish to eliminate any insects that could be carrying the virus. It has also triggered alarm in the US, with CDC officials saying they are 'assessing' the situation and warning Americans to take protective measures, such as wearing insect repellent or long-sleeved clothes if they travel to the area. Experts in the US say the disease is just 'one plane ride' from reaching American shores. China's record-breaking outbreak is in Guangdong province, on the southern coast, with almost all the infections reported in the city of Foshan. In the latest update from the Guangdong Provincial Center for Disease Control and Prevention, revealed by the Yangcheng Evening News, officials reported that of the new cases, 1,212 were in Foshan. Another 103 cases were reported in Guangzhou, the largest city in the province, while 39 cases were reported in Zhanjiang. It was not clear where the other 33 cases were within the province. Officials heralded the figures as the lowest weekly count reported since the peak of the outbreak in the week to July 20 to 26, when they said they recorded 2,940 cases. In a statement to last week, a CDC spokesman said: 'CDC is aware of the reported chikungunya outbreak in Guangdong Province in China and is currently assessing the size and extent of the outbreak.' The agency has already issued a level two warning for the area, advising Americans to take advanced precautions when traveling to the region. On Friday, Hong Kong said it had detected another two cases linked to the outbreak, taking its chikungunya tally to five infections reported this year. One was a 66-year-old woman who was reported to have traveled to Foshan alone from July 24 to August 5 to see family, before returning to Hong Kong. The patient began suffering from fever, rash and joint pain on August 6 and went to the hospital. She has now been discharged. It also reported another suspected case in a healthy 22-year-old woman who was suffering from joint pain and fever. She had recently traveled to Madagascar, Mauritius and Malaysia before returning to the territory, and reported having been bitten by mosquitoes during her trip. Also on Friday, Taiwan reported its first case linked to the outbreak in China, in a woman in her 40s who had recently returned from Foshan and Shenzhen. A day after returning to Taiwan she developed a fever, rash and pain in her limbs. Officials said she was admitted to the hospital. She also reported being bitten by mosquitoes. Chikungunya virus can only be spread via the bites of mosquitoes and cannot be passed from human to human. People infected with the virus suffer from a sudden high fever, normally around 103 Fahrenheit (39 Celsius), which happens within two to seven days of infection. They may also suffer from a rash, headache, nausea, fatigue and joint pain. In serious cases, patients may suffer from pain in the hands and feet that is so bad it leaves them struggling to carry out normal activities. It is rarely fatal, but can leave people with lifelong complications including joint inflammation and pain that lasts for years. Patients who are very young, elderly or have underlying conditions are most at risk because of their weakened immune systems. There is no treatment for the virus, with doctors instead using over-the-counter painkillers, fluids and rest to ease symptoms. There are two vaccines available. The US records more than 100 cases of chikungunya virus every year, with almost all normally linked to travelers returning from abroad before testing positive for the virus. Experts are concerned, however, that an infected individual could be bitten by a mosquito, which would then become infected and pass the disease on to others. A total of 45 chikungunya cases have been reported in the US this year, although none have been linked to the outbreak in China.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store